News for 'drug quality'

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

WHO issues alert against Indian cough syrups. They are...

WHO issues alert against Indian cough syrups. They are...

Rediff.com14 Oct 2025

The World Health Organisation (WHO) has issued an alert against three "substandard" oral cough syrups identified in India and urged national regulatory authorities worldwide to immediately notify it if these are detected in their country.

Adulterated Drugs On Decline Amid Crackdown

Adulterated Drugs On Decline Amid Crackdown

Rediff.com10 Oct 2024

Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs.

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Rediff.com30 Jun 2025

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.

India's Space Manufacturing Boom

India's Space Manufacturing Boom

Rediff.com15 Aug 2025

The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.

Caterer's licence suspended after Shiv Sena MLA's assault

Caterer's licence suspended after Shiv Sena MLA's assault

Rediff.com10 Jul 2025

The Maharashtra Food and Drugs Administration (FDA) has suspended the license of a caterer that operates the canteen at the MLA hostel in Mumbai, after a Shiv Sena legislator assaulted a staffer for allegedly serving stale food.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

States Seek Centre's Help To Deal With Trump's Tariffs

States Seek Centre's Help To Deal With Trump's Tariffs

Rediff.com2 Sep 2025

State governments have requested the Centre for export incentives, lifting of import duty in the case of cotton for the textile sector and GST exemptions.

Lokah Review: Intriguing!

Lokah Review: Intriguing!

Rediff.com1 Sep 2025

The Kalyani Priyadarshan starrer is the kind of incentive superhero origin story that can alter the way such films are made in Malayalam cinema, feels Arjun Menon.

The C P Radhakrishnan You Didn't Know

The C P Radhakrishnan You Didn't Know

Rediff.com9 Sep 2025

'In my 26 years at Raj Bhavan, working with more than ten governors, I can tell you C P Radhakrishnan Sir stands out.'

CBI brings back 'meow meow' kingpin from UAE

CBI brings back 'meow meow' kingpin from UAE

Rediff.com11 Jul 2025

An alleged synthetic narcotics producer, Kubbawala Mustafa, wanted on an Interpol Red Notice, was deported to India from the UAE in an operation coordinated by the CBI and Mumbai police.

Shortcuts Won't Build Industrial Capability

Shortcuts Won't Build Industrial Capability

Rediff.com28 Jul 2025

Any industrial policy is only as good as how it is applied and the other reforms that support it. This was as true 40 years ago as it is now, points out Debashis Basu.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

Why Are Child TB Cases Rising?

Why Are Child TB Cases Rising?

Rediff.com17 Apr 2025

Children below the age of 15 years account for about 10 to 12 per cent of India's overall TB burden.

Record 3,300 kg of drugs seized off Gujarat coast in major drug haul

Record 3,300 kg of drugs seized off Gujarat coast in major drug haul

Rediff.com29 Feb 2024

The drugs seized include 3,089 kilograms of charas, 158 kg of Methamphetamine and 25 kg of morphine.

USTR flags hurdles in medical device exports to India

USTR flags hurdles in medical device exports to India

Rediff.com2 Apr 2025

The USTR report, released just ahead of the US' April 2 deadline for implementing reciprocal tariffs, has also cited high tariffs and price caps, which have not increased in line with inflation, as key obstacles for US businesses.

Why Drug Prices Won't Increase This Year

Why Drug Prices Won't Increase This Year

Rediff.com5 Apr 2024

The government has been stringent with pricing changes. Prices of 651 essential medicines came down from April 1, 2023 by 6.73 per cent with the government capping ceiling prices of these drugs.

Over 2,900 drugs found to be substandard, 422 spurious, govt tells RS

Over 2,900 drugs found to be substandard, 422 spurious, govt tells RS

Rediff.com19 Dec 2023

Minister of State for Health Bharati Pravin Pawar said 642 prosecutions were launched for manufacturing, sale and distribution of spurious/adulterated drugs, while 262 persons were arrested.

Fake medicines worth Rs 6.6 crore seized in Kolkata

Fake medicines worth Rs 6.6 crore seized in Kolkata

Rediff.com1 Jan 2025

'Anti-cancer, anti-diabetic, and other drugs suspected to be spurious were seized from the raid carried out at the firm.'

Industry bodies seek safeguards against influx of Chinese goods

Industry bodies seek safeguards against influx of Chinese goods

Rediff.com26 Apr 2025

Various industry bodies have sought immediate government intervention through the imposition of anti-dumping duties, claiming India has seen a surge in imports of Chinese goods over the past two weeks.

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).

India maintains high import duty on American goods: US report

India maintains high import duty on American goods: US report

Rediff.com1 Apr 2025

India maintains "high" import duties on a wide range of American goods such as agricultural items, drug formulations, and alcoholic beverages, besides imposing non-tariif barriers, a US report has said. A day before announcing reciprocal tariffs, the US Trade Representative (USTR) released the 2025 National Trade Estimate (NTE) Report on March 31.

Equity market volatility may persist; long-term outlook remains constructive: Experts

Equity market volatility may persist; long-term outlook remains constructive: Experts

Rediff.com3 Apr 2025

The heightened global uncertainty due to the US "reciprocal tariffs" on India may cause near-term corrections and market turbulence, but the long-term outlook remains constructive, market experts said on Thursday. The US has announced 27 per cent reciprocal tariffs on India, citing high import duties imposed by New Delhi on American goods.

10 Medical Streams After Class 12

10 Medical Streams After Class 12

Rediff.com15 May 2025

While MBBS continues to be the most sought-after stream for medical aspirants, post pandemic, the demand for skilled nurses and physiotherapists are on the rise, notes Nayagam PP, career counsellor and founder of EduJob360.

GOOD News! No Drug Price Hike In 2024

GOOD News! No Drug Price Hike In 2024

Rediff.com6 Feb 2024

For the consumer, there would be practically no impact on prices of essential medicines this year.

Doctors not prescribing generic drugs to be penalised

Doctors not prescribing generic drugs to be penalised

Rediff.com13 Aug 2023

All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for a period, according to the new regulations issued by the National Medical Commission (NMC).

NMC stays generic drugs rule for doctors, bar on endorsing drugs

NMC stays generic drugs rule for doctors, bar on endorsing drugs

Rediff.com24 Aug 2023

Members of the IMA and IPA had met Mansukh Mandaviya on Monday and expressed their concerns over the regulations.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

This will Likely Shape the Future of Pharma Inc

This will Likely Shape the Future of Pharma Inc

Rediff.com8 Mar 2025

Indian pharmaceutical companies may have units abroad as part of "distributed manufacturing" across various locations, according to industry veterans. This may come about over the next five to 10 years.

Checks On Drug-Making Units Begins

Checks On Drug-Making Units Begins

Rediff.com29 Dec 2022

The joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country

Empuraan Review: Return Of The King

Empuraan Review: Return Of The King

Rediff.com27 Mar 2025

L2: Empuraan is an ambitious sequel that is bigger, bolder and timid in equal measure, observes Arjun Menon.

India's Medtech Industry To Develop High-end Equipment

India's Medtech Industry To Develop High-end Equipment

Rediff.com17 Apr 2025

According to the Department of Pharmaceuticals' annual report for 2024-25, India imported medical devices worth $8.1 billion, while exports stood at $3.7 billion in the financial year 2023-24 (FY24)

MBA, LLB students among 9 held for drug trafficking in Noida

MBA, LLB students among 9 held for drug trafficking in Noida

Rediff.com27 Nov 2023

The arrests have been made by officials of Sector 126 police station as part of a crackdown on narcotics ordered by police commissioner Laxmi Singh, deputy commissioner of police (Noida) Harish Chander said.

US Firms Back Trump's India Tariffs

US Firms Back Trump's India Tariffs

Rediff.com31 Mar 2025

Industry associations and companies in the United States, including the US Chamber of Commerce, Coalition of Services Industries and the iconic bike company Harley Davidson have called on the Donald Trump dispensation to push India to reduce tariffs, non-tariffs, and regulatory barriers to boost American exports.

'Zero-For-Zero Tariff Is Best Medicine For India'

'Zero-For-Zero Tariff Is Best Medicine For India'

Rediff.com21 Apr 2025

'No retaliatory tariffs now. You can retaliate after a few months.' 'Today, there is no need to retaliate because it is a question of long term benefits.'

Pharma companies fight fakes with smart packaging

Pharma companies fight fakes with smart packaging

Rediff.com10 Oct 2024

Indian pharmaceutical companies are stepping up their efforts to combat the problem of counterfeit drugs, employing a variety of strategies, from packaging innovations to engaging private investigation agencies. The stakes are high, as counterfeit medicines not only harm consumers but also tarnish the reputation of leading brands.

Are Indian drugs safe? US doctors worried over quality

Are Indian drugs safe? US doctors worried over quality

Rediff.com18 Mar 2014

Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

'BJP Will Come To Power In Kerala In 2026'

'BJP Will Come To Power In Kerala In 2026'

Rediff.com10 Apr 2025

'In today's political spectrum, it is the Bharatiya Janata Party that always says, nation first.'

Budget 2025: Grassroot Level Implementation Is Necessary

Budget 2025: Grassroot Level Implementation Is Necessary

Rediff.com5 Feb 2025

Simplifying investment policies at the micro level and introducing a time-bound framework will be critical for India's growth targets, notes Krishna Ella.